These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8240739)

  • 21. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The induction of transplantation tolerance by intrathymic (i.t.) delivery of alloantigen: a critical relationship between i.t. deletion, thymic export of new T cells and the timing of transplantation.
    Jones ND; Fluck NC; Mellor AL; Morris PJ; Wood KJ
    Int Immunol; 1998 Nov; 10(11):1637-46. PubMed ID: 9846692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complementary roles of deletion and regulation in transplantation tolerance.
    Lechler RI; Garden OA; Turka LA
    Nat Rev Immunol; 2003 Feb; 3(2):147-58. PubMed ID: 12563298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
    Garrovillo M; Ali A; Oluwole SF
    Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral tolerance to alloantigen: strategies for the future.
    Wood KJ
    Eur J Immunogenet; 1993 Oct; 20(5):439-49. PubMed ID: 9098412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
    Madsen JC; Superina RA; Wood KJ; Morris PJ
    Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
    Beilke JN; Kuhl NR; Van Kaer L; Gill RG
    Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathymic injection of alloantigen.
    Fabrega AJ; Pollak R
    Transplantation; 1995 Jan; 59(1):157. PubMed ID: 7839422
    [No Abstract]   [Full Text] [Related]  

  • 33. Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules.
    Gamadia LE; Remmerswaal EB; Surachno S; Lardy NM; Wertheim-van Dillen PM; van Lier RA; ten Berge IJ
    Transplantation; 2004 Jun; 77(12):1879-85. PubMed ID: 15223907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC structure and function.
    Thorsby E
    Transplant Proc; 1999; 31(1-2):713-6. PubMed ID: 10083306
    [No Abstract]   [Full Text] [Related]  

  • 36. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
    Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
    Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloantigen processing and presentation.
    Tambur AR; Gebel HM
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance and the "Holy Grail" of transplantation.
    Schroeder RA; Marroquin CE; Kuo PC
    J Surg Res; 2003 May; 111(1):109-19. PubMed ID: 12842455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance and long-lasting peripheral chimerism after allogeneic intestinal transplantation in MGH miniature swine.
    Ishikawa Y; Hirakata A; Griesemer AD; Etter J; Moran S; Weiner J; Shimizu A; Yamada K
    Transplantation; 2010 Feb; 89(4):417-26. PubMed ID: 20177343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.